Institute of Pathology

Neurogenic tachykinin mechanisms in experimental nephritis of rats (2020) Rodionova K, Hilgers KF, Paulus EM, Tiegs G, Ott C, Schmieder R, Schiffer M, et al. Journal article Integrating Genomics and Clinical Data for Statistical Analysis by Using GEnome MINIng (GEMINI) and Fast Healthcare Interoperability Resources (FHIR): System Design and Implementation (2020) Gründner J, Wolf N, Tögel L, Haller F, Prokosch HU, Christoph J Journal article Piwi-like 1 and piwi-like 2 expression in breast cancer (2020) Erber R, Meyer J, Taubert H, Fasching P, Wach S, Häberle L, Gaß P, et al. Journal article MONITORING OF GENERAL IMMUNE STATUS AND SARS-COV-2 REACTIVE T-CELL AND HUMORAL IMMUNITY FACILITATES THE CLINICAL DECISION IN A SEVERE SARS-COV-2-ASSOCIATED PNEUMONIA, MENINGOENCEPHALITIS AND GASTROENTERITIS IN A PANCREAS-KIDNEY TRANSPLANT PATIENT (2020) Babel N, Stervbo U, Seibert F, Bauer F, Anft M, Rohn B, Winnekendonk G, et al. Conference contribution ALLOGRAFT INFILTRATION AND MENINGOENCEPHALITIS BY SARS-COV-2 IN A PANCREAS-KIDNEY TRANSPLANT RECIPIENT (2020) Doevelaar A, Seibert F, Bauer F, Stervbo U, Anft M, Rohn B, Winnekendonk G, et al. Conference contribution INTERLEUKIN-21-A NEW PLAYER IN ALLOGRAFT REJECTION? (2020) Steines L, Friedmann J, Schuster A, Poth H, Amann KU, Banas B, Bergler T Conference contribution DISRUPTION OF TFH:B CELL CROSSTALK PREVENTS ANTIBODY-MEDIATED REJECTION IN AN EXPERIMENTAL KIDNEY TRANSPLANT MODEL (2020) Steines L, Poth H, Schuster A, Amann KU, Banas B, Bergler T Conference contribution Influence of the Family Anamnesis of Breast or Ovarian Cancer on the pathological Complete Remission and the Prognosis in Patients with Breast Cancer after neoadjuvant Chemotherapy (2020) Gaß P, Haberle L, Hein A, Jud S, Lux MP, Hack C, Emons J, et al. Conference contribution Accuracy of vulvoscopic findings in detecting early vulvar neoplasia (2020) Stuebs FA, Mehlhorn G, Gaß P, Schulmeyer C, Adler W, Strehl J, Hartmann A, et al. Conference contribution Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup (2020) Emons J, Fasching P, Wunderle M, Heindl F, Rieger J, Horn F, Pelzer G, et al. Conference contribution